Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
NCT ID: NCT00296387
Last Updated: 2007-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
1160 participants
INTERVENTIONAL
2006-01-31
2007-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Rosuvastatin
Atorvastatin
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Percutaneous coronary intervention (PCI) planned,
* Evidence of coronary artery disease
Exclusion Criteria
* Any cholesterol lowering medication taken within 1 month prior V1
* Sustained ST-segment elevation on ECG
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
AstraZeneca
INDUSTRY
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
AstraZeneca France Medical Director, MD
Role: STUDY_DIRECTOR
AstraZeneca
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Research Site
Aalst, , Belgium
Research Site
Bonheiden, , Belgium
Research Site
Bouge, , Belgium
Research Site
Brussels, , Belgium
Research Site
Charleroi, , Belgium
Research Site
Hasselt, , Belgium
Research Site
Huy, , Belgium
Research Site
La Louvière, , Belgium
Research Site
Leuven, , Belgium
Research Site
Edmonton, Alberta, Canada
Research Site
Vancouver, British Columbia, Canada
Research Site
Victoria, British Columbia, Canada
Research Site
Winnipeg, Manitoba, Canada
Research Site
Saint John, New Brunswick, Canada
Research Site
St. John's, Newfoundland and Labrador, Canada
Research Site
Halifax, Nova Scotia, Canada
Research Site
Kingston, Ontario, Canada
Research Site
London, Ontario, Canada
Research Site
Scarborough Village, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Laval, Quebec, Canada
Research Site
Montreal, Quebec, Canada
Research Site
Pointe-Claire, Quebec, Canada
Research Site
Saint-Charles-Borromée, Quebec, Canada
Research Site
Sherbrooke, Quebec, Canada
Research Site
Regina, Saskatchewan, Canada
Research Site
Tallinn, , Estonia
Research Site
Tartu, , Estonia
Research Site
Amiens, , France
Research Site
Annecy, , France
Research Site
Arras, , France
Research Site
Avignon, , France
Research Site
Boulogne-Billancourt, , France
Research Site
Caen, , France
Research Site
Cholet, , France
Research Site
Créteil, , France
Research Site
Dijon, , France
Research Site
Eaubonne, , France
Research Site
Évecquemont, , France
Research Site
Falaise, , France
Research Site
La Roche-sur-Yon, , France
Research Site
Lagny-sur-Marne, , France
Research Site
Le Coudray, , France
Research Site
Le Mans, , France
Research Site
Lille, , France
Research Site
Marseille, , France
Research Site
Metz, , France
Research Site
Montpellier, , France
Research Site
Nevers, , France
Research Site
Paris, , France
Research Site
Pau, , France
Research Site
Pessac, , France
Research Site
Reims, , France
Research Site
Rouen, , France
Research Site
Saint-Herblain, , France
Research Site
Suresnes, , France
Research Site
Toulouse, , France
Research Site
Tourcoing, , France
Research Site
Tours, , France
Research Site
Valenciennes, , France
Research Site
Vannes, , France
Research Site
Villeurbanne, , France
Research Site
Athens, , Greece
Research Site
Balatonfüred, , Hungary
Research Site
Budapest, , Hungary
Research Site
Pécs, , Hungary
Research Site
Zalaegerszeg, , Hungary
Research Site
Dublin, , Ireland
Research Site
Galway, , Ireland
Research Site
Limerick, , Ireland
Research Site
Bari, Apulia, Italy
Research site
Cosenza, Basilicate, Italy
Research Site
Benevento, Campania, Italy
Research Site
Mantova, Lombardy, Italy
Research Site
Rozzano (Milano), Lombardy, Italy
Research Site
Catania, Sicily, Italy
Research Site
Pisa, Tuscany, Italy
Research Site
Perugia, Umbria, Italy
Research Site
Verona, Veneto, Italy
Research Site
Bolzano, , Italy
Research Site
Napoli, , Italy
Research Site
Padua, , Italy
Research Site
Roma, , Italy
Research Site
Aveiro, , Portugal
Research Site
Braga, , Portugal
Research Site
Carnaxide, , Portugal
Research Site
Faro, , Portugal
Research Site
Funchal, , Portugal
Research Site
Leiria, , Portugal
Research Site
Vila Real, , Portugal
Research Site
Zaragoza, Aragon, Spain
Research Site
Toledo, Castille-La Mancha, Spain
Research Site
Tarragona, Catalonia, Spain
Research Site
Fuenlabrada(Madrid), Madrid, Spain
Research site
Madrid, Madrid, Spain
Research Site
Vigo, Pontevedra, Spain
Research Site
Sant Joan d'Alacant, Valencia, Spain
Research Site
Seville, , Spain
Research Site
BAB Saâdoun Tunis, , Tunisia
Research Site
SIDI Daoud Tunis, , Tunisia
Research Site
Sousse, , Tunisia
Research Site
Tunis, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lablanche JM, Leone A, Merkely B, Morais J, Alonso J, Santini M, Eha J, Demil N, Licour M, Tardif JC; CENTAURUS investigators. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study. Arch Cardiovasc Dis. 2010 Mar;103(3):160-9. doi: 10.1016/j.acvd.2010.01.005. Epub 2010 Apr 8.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CENTAURUS
Identifier Type: -
Identifier Source: secondary_id
D3560L00052
Identifier Type: -
Identifier Source: org_study_id